Li H - Search Results

1

Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.

Deng KQ, Zhao GN, Wang Z, Fang J, Jiang Z, Gong J, Yan FJ, Zhu XY, Zhang P, She ZG, Li H. Deng KQ, et al. Among authors: li h. Circulation. 2018 Apr 3;137(14):1486-1504. doi: 10.1161/CIRCULATIONAHA.117.031659. Epub 2017 Dec 11. Circulation. 2018. PMID: 29229612

2

A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages.

Li HL, Wang AB, Zhang R, Wei YS, Chen HZ, She ZG, Huang Y, Liu DP, Liang CC. Li HL, et al. J Cell Physiol. 2006 Aug;208(2):307-18. doi: 10.1002/jcp.20665. J Cell Physiol. 2006. PMID: 16646083

3

A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo.

Wang AB, Li HL, Zhang R, She ZG, Chen HZ, Huang Y, Liu DP, Liang CC. Wang AB, et al. J Biomed Sci. 2007 May;14(3):357-71. doi: 10.1007/s11373-007-9150-x. Epub 2007 Jan 29. J Biomed Sci. 2007. PMID: 17260188

4

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.

Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC. Li HL, et al. Circulation. 2007 Apr 10;115(14):1885-94. doi: 10.1161/CIRCULATIONAHA.106.656835. Epub 2007 Mar 26. Circulation. 2007. PMID: 17389268

5

Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.

Li HL, She ZG, Li TB, Wang AB, Yang Q, Wei YS, Wang YG, Liu DP. Li HL, et al. Hypertension. 2007 Jun;49(6):1399-408. doi: 10.1161/HYPERTENSIONAHA.106.085399. Epub 2007 Apr 9. Hypertension. 2007. PMID: 17420335

6

Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.

She ZG, Zheng W, Wei YS, Chen HZ, Wang AB, Li HL, Liu G, Zhang R, Liu JJ, Stallcup WB, Zhou Z, Liu DP, Liang CC. She ZG, et al. Circ Res. 2009 May 22;104(10):1160-8. doi: 10.1161/CIRCRESAHA.108.192229. Epub 2009 Apr 9. Circ Res. 2009. PMID: 19359600

7

LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.

Bian ZY, Huang H, Jiang H, Shen DF, Yan L, Zhu LH, Wang L, Cao F, Liu C, Tang QZ, Li H. Bian ZY, et al. Among authors: li h. Hypertension. 2010 Feb;55(2):257-63. doi: 10.1161/HYPERTENSIONAHA.109.135665. Epub 2009 Dec 21. Hypertension. 2010. PMID: 20026769

8

Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

Shen DF, Tang QZ, Yan L, Zhang Y, Zhu LH, Wang L, Liu C, Bian ZY, Li H. Shen DF, et al. Among authors: li h. Br J Pharmacol. 2010 Feb;159(4):970-81. doi: 10.1111/j.1476-5381.2009.00605.x. Epub 2010 Jan 25. Br J Pharmacol. 2010. PMID: 20105174 Free PMC article.

9

Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.

Yan L, Huang H, Tang QZ, Zhu LH, Wang L, Liu C, Bian ZY, Li H. Yan L, et al. Among authors: li h. J Cell Biochem. 2010 Apr 15;109(6):1158-71. doi: 10.1002/jcb.22495. J Cell Biochem. 2010. PMID: 20127712

10

Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.

Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C, Huang H, Bai X, Yin L, Li H. Ai W, et al. Among authors: li h. J Cell Biochem. 2010 Aug 1;110(5):1111-22. doi: 10.1002/jcb.22623. J Cell Biochem. 2010. PMID: 20564207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122,577 results

Search Page

Filters